Practical fundamentals of glass, rubber, and plastic sterile packaging systems
- PMID: 20088708
- DOI: 10.3109/10837450903511178
Practical fundamentals of glass, rubber, and plastic sterile packaging systems
Abstract
Sterile product packaging systems consist of glass, rubber, and plastic materials that are in intimate contact with the formulation. These materials can significantly affect the stability of the formulation. The interaction between the packaging materials and the formulation can also affect the appropriate delivery of the product. Therefore, a parenteral formulation actually consists of the packaging system as well as the product that it contains. However, the majority of formulation development time only considers the product that is contained in the packaging system. Little time is spent studying the interaction of the packaging materials with the contents. Interaction between the packaging and the contents only becomes a concern when problems are encountered. For this reason, there are few scientific publications that describe the available packaging materials, their advantages and disadvantages, and their important product attributes. This article was created as a reference for product development and describes some of the packaging materials and systems that are available for parenteral products.
Similar articles
-
The impact of primary packaging on the quality of parenteral products.J Pharm Biomed Anal. 2008 Nov 4;48(3):744-8. doi: 10.1016/j.jpba.2008.07.025. Epub 2008 Aug 8. J Pharm Biomed Anal. 2008. PMID: 18786797
-
Drug sorption to glass and plastics.Drug Metabol Drug Interact. 1988;6(1):1-45. Drug Metabol Drug Interact. 1988. PMID: 3069325 Review.
-
Performance Stability of Silicone Oxide-Coated Plastic Parenteral Vials.PDA J Pharm Sci Technol. 2017 Jul-Aug;71(4):317-327. doi: 10.5731/pdajpst.2016.007278. Epub 2017 Apr 17. PDA J Pharm Sci Technol. 2017. PMID: 28416645
-
Selection of plastic containers for pharmaceuticals.Polim Med. 1977;7(2):91-7. Polim Med. 1977. PMID: 600885
-
Immunogenicity of therapeutic proteins. Part 2: impact of container closures.Biotechnol Adv. 2007 May-Jun;25(3):318-24. doi: 10.1016/j.biotechadv.2007.01.006. Epub 2007 Jan 30. Biotechnol Adv. 2007. PMID: 17337336 Review.
Cited by
-
Rapid reconstitution packages (RRPs) for stable storage and delivery of glucagon.Drug Deliv Transl Res. 2019 Jun;9(3):631-640. doi: 10.1007/s13346-019-00615-4. Drug Deliv Transl Res. 2019. PMID: 30719629
-
Analytical microscopy techniques using coaxial and oblique illuminations to detect thin glass particulates generated from glass vials for parenteral drug products.Appl Microsc. 2024 Oct 23;54(1):9. doi: 10.1186/s42649-024-00101-3. Appl Microsc. 2024. PMID: 39441435 Free PMC article.
-
Protein particulate detection issues in biotherapeutics development--current status.AAPS PharmSciTech. 2012 Jun;13(2):732-46. doi: 10.1208/s12249-012-9793-4. Epub 2012 May 8. AAPS PharmSciTech. 2012. PMID: 22566174 Free PMC article. Review.
-
Issues with Intravitreal Administration of Anti-VEGF Drugs.Clin Ophthalmol. 2020 Mar 23;14:897-904. doi: 10.2147/OPTH.S207978. eCollection 2020. Clin Ophthalmol. 2020. PMID: 32256047 Free PMC article. Review.
-
Exploring Possible Mechanisms of Hormesis and Homeopathy in the Light of Nanopharmacology and Ultra-High Dilutions.Dose Response. 2021 Jun 14;19(2):15593258211022983. doi: 10.1177/15593258211022983. eCollection 2021 Apr-Jun. Dose Response. 2021. PMID: 34177397 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources